Literature DB >> 6661434

Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen.

T J Janus, S D Lewis, L Lorand, J A Shafer.   

Abstract

High-performance liquid chromatography was used to analyze the kinetics of the thrombin-catalyzed release of the activation peptide from the factor XIII zymogen (fibrin-stabilizing factor). The specificity constant (kcat/Km) for this reaction, measured at factor XIII concentrations much below Km, was (0.13-0.16) X 10(6) M-1 s-1 at pH 7.4, mu = 0.15, and 37 degrees C. Separate estimates, obtained from the dependence of the initial rates of release of the activation peptide on the concentration of factor XIII, gave values of 10 (+/- 3) s-1 for kcat and 84 (+/- 30) microM for Km, in terms of ab protomers of the zymogen. The thrombin-mediated release of the activation peptide was dramatically enhanced in the presence of fibrinogen. Furthermore, the time course of release, in relation to that of fibrinopeptide A, suggested that some des-A-fibrinogen species (e.g., alpha 2B beta 2 gamma 2) may be the true activator for promoting the cleavage of the Arg-36 peptide bonds in the a subunits of factor XIII. This observation suggests that generation of factor XIIIa and its substrate (fibrin) is coordinated so that thrombin-mediated zymogen activation proceeds efficiently only after the process of clotting has been initiated by the removal of fibrinopeptide A from fibrinogen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6661434     DOI: 10.1021/bi00295a035

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.

Authors:  Kevin R Siebenlist; Michael W Mosesson; Irene Hernandez; Leslie A Bush; Enrico Di Cera; John R Shainoff; James P Di Orio; Laurie Stojanovic
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

2.  The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking.

Authors:  Masayoshi Souri; Tsukasa Osaki; Akitada Ichinose
Journal:  J Biol Chem       Date:  2015-03-25       Impact factor: 5.157

3.  Fibrin assembly after fibrinopeptide A release in model systems and human plasma studied with magnetic birefringence.

Authors:  J Torbet
Journal:  Biochem J       Date:  1987-06-15       Impact factor: 3.857

4.  Isolation of a fibrin-binding fragment from blood coagulation factor XIII capable of cross-linking fibrin(ogen).

Authors:  C S Greenberg; J J Enghild; A Mary; J V Dobson; K E Achyuthan
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

5.  The influence of type 2 diabetes on fibrin structure and function.

Authors:  E J Dunn; R A S Ariëns; P J Grant
Journal:  Diabetologia       Date:  2005-04-29       Impact factor: 10.122

Review 6.  Molecular mechanisms affecting fibrin structure and stability.

Authors:  Susan T Lord
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03       Impact factor: 8.311

Review 7.  Viscoelasticity and Ultrastructure in Coagulation and Inflammation: Two Diverse Techniques, One Conclusion.

Authors:  Albe C Swanepoel; Vance G Nielsen; Etheresia Pretorius
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

8.  Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.

Authors:  C S Greenberg; C C Miraglia; F R Rickles; M A Shuman
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

9.  The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues γ390-396 and the FXIII-B subunits.

Authors:  James R Byrnes; Clare Wilson; Anthony M Boutelle; Chase B Brandner; Matthew J Flick; Helen Philippou; Alisa S Wolberg
Journal:  Blood       Date:  2016-08-25       Impact factor: 22.113

10.  Autoimmune antibody (IgG Kansas) against the fibrin stabilizing factor (factor XIII) system.

Authors:  L Lorand; P T Velasco; J R Rinne; M Amare; L K Miller; M L Zucker
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.